Martyn R. Sholtis

Martyn R. Sholtis discloses dealings in Rochester Medical Corporation to SEC (Form 4). Over a trading history stretching from 21 November 2006 to 14 November 2013, the count stands at 66 filings.

The open-market side counts 1 purchase for €7,800 alongside 47 sales for €1.3M. On balance, insiders were net sellers of €1.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 share grants and 14 option exercises. 2013 to date brings 1 purchase and 4 sales.

The latest filing, published on 18 November 2013, reports a share grant in Rochester Medical Corporation. The clock since the last published purchase (5 March 2013) now reads 4,980 days. The median gap between a trade and its publication by SEC (Form 4) is 8 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.